Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
VTYX
#2091
Ventyx Biosciences, Inc. Common Stock
13.9
7
-0.07%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-0.07%
Monatliche Änderung
-0.07%
6 month change
+454.37%
Jahresänderung
+837.58%
Vorheriger Schlusskurs
13.9
8
Open
13.9
7
Bid
Ask
Low
13.9
7
High
13.9
7
Volumen
75
Märkte
Aktien
Gesundheitswesen
VTYX
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
70.71 M
71.13 M
71.16 M
71.31 M
71.36 M
—
Valuation ratios
Enterprise value
92.38 M
128.51 M
53.76 M
120.3 M
189.96 M
492.53 M
Price to earnings ratio
-0.92
-1.11
-0.68
-1.32
-2.16
-5.27
Price to sales ratio
—
1 102.7
—
—
—
—
Price to cash flow ratio
-0.86
-1.15
-0.72
-1.4
-2.5
-5.77
Price to book ratio
0.12
0.59
0.08
0.15
0.25
1.06
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.12
0.11
0.11
0.12
0.11
0.44
Return on equity %
0.13
0.12
0.12
0.13
0.12
0.48
Return on invested capital %
—
—
—
—
—
—
Gross margin %
—
100
—
—
—
—
Operating margin %
—
90.05 K
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
81.53 K
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
23.52
17.97
19.57
19.12
17.86
74.53
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.5
0.34
0.36
0.3
0.25
1.25
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
3.89
3.69
3.22
2.93
2.7
12.55
Net current asset value per share
4.1
3.35
3.41
3.08
2.82
12.66
Tangible book value per share
3.94
3.71
3.26
2.94
2.68
12.59
Working capital per share
3.92
3.17
3.24
2.92
2.66
11.98
Book value per share
3.94
3.71
3.26
2.94
2.68
12.59
Nachrichten
Lilly Stock Jumps After Q4 Earnings Beat and Strong 2026 Guidance
Ventyx Biosciences approves cash bonus awards for executives ahead of planned merger
Why Eli Lilly Is The IBD Stock Of The Day — Again — As Its Novo Nordisk Rivalry Deepens
Dow Jones Retail Giant Amazon Stock Eyes Latest Buy Point
BioAge Rockets As It Takes On Eli Lilly's Takeover Play, Ventyx Bio
Eli Lilly Stock Broke Out Following Plan To Acquire Ventyx Biosciences
Stock Market Rallies Broadly To Highs; Nvidia, AMD, Bloom Energy In Focus: Weekly Review
Healthcare dealmakers head to San Francisco hoping for megamergers in 2026
Biotech Stocks' Dark Winter Is Over. What That Means For Investors.
Eli Lilly (LLY) Buys Ventyx Biosciences in $1.2 Billion Deal - TipRanks.com
Is LLY's Ventyx Deal Another Attempt at Diversification Beyond GLP-1?
Eli Lilly übernimmt Ventyx Biosciences für 1,2 Milliarden US-Dollar